Human NMNAT1 (Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1) ELISA KIT (HUFI05013)

Researchers investigating nicotinamide adenine dinucleotide biosynthesis pathways can use this Assay Genie NMNAT1 immunoassay to quantify nuclear adenylyltransferase activity in human-derived specimens. NMNAT1 catalyzes the final step of NAD+ salvage, converting nicotinamide mononucleotide and ATP into NAD+ and pyrophosphate, and loss-of-function mutations in the NMNAT1 gene cause Leber Congenital Amaurosis type 9, a severe inherited retinal dystrophy. The kit supports in vitro studies of cellular metabolism, oxidative stress responses, and age-related neurodegeneration in research use only workflows, including cell culture models and tissue lysate preparation. Each kit contains reagents sufficient for 96 Assays, and components should be stored refrigerated to preserve enzymatic reactivity standards until first use.